Global Malaria Diagnostics Market Opportunities and Forecast 2023-2030

  •   DLR2418
  •   April, 2022
  •   Pages: 120
  •  Global
Malaria Diagnostics Market Overview

Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. The major factors such as the increasing prevalence of malaria in developing countries, rising demand for malaria diagnostics, and the introduction of novel diagnostic techniques are contributing significantly to boost the growth of the Malaria Diagnostics market. According to World Health Organization, in 2019, there were an estimated 229 million cases of malaria worldwide. The estimated number of malaria deaths stood at 409 000 in 2019. Additionally, the WHO African Region carries a disproportionately high share of the global malaria burden. In 2019, the region was home to 94% of malaria cases and deaths.

Furthermore, heavy investments by government bodies and private investors to curb the disease prevalence is also one of the major factors to propel the growth of the market. According to the data published by WHO, total funding for malaria control and elimination reached an estimated US$ 3 billion in 2019. Also, contributions from governments of endemic countries amounted to US$ 900 million, representing 31% of total funding.

However, lack of awareness about healthcare in developing countries is a major factor that restricts the malaria diagnostics market growth.

Malaria Diagnostics Market Segment Overview

According to Technology, Rapid Diagnostic Tests (RDTs) segment is expected to command the largest share of the market. This is due to benefits related to the use of RDTs in the diagnosis of malaria. Additionally, RDTs are low-cost, simple to operate and read, highly sensitive & specific, stable at high temperatures, and provide results quickly. Hence, it contributes more to the growth of the malaria diagnostic market. According to the data published by WHO, Globally, 2.7 billion RDTs for malaria were sold between 2010–2019. Moreover, the molecular diagnostic tests segment is the fastest-growing segment in the market. This is mainly due to the high specificity related to the use of the test, which can lead to better treatment outcomes.

Malaria Diagnostics Market Regional Overview

Region-wise, Europe and the Asia Pacific accounted for the major share of the malaria diagnostics market. This is due to the rapid surge in the prevalence of malaria in these regions. Additionally, the steps were taken by the government to spread awareness about the disease, its treatment, and prevention are expected to drive the growth of the market.  This situation is mostly seen in developing countries such as the Asia Pacific and the Rest of the World. For instance, the commitment of the Government of India to eliminate malaria by endorsing the Global Malaria Technical Strategy 2016-2030 and setting a national malaria elimination target of 2030 is a huge step forward that will have a major regional and global impact.

Malaria Diagnostics Market, Key Players

·       Beckman Coulter/Danaher
·       Abbott Laboratories
·       Bio-Rad Laboratories, Inc.
·       Novartis Diagnostics
·       Life Technology
·       Siemens Healthcare
·       Bio-Rad
·       Ortho-Clinical Diagnostics
·       Wako Chemicals, Inc.

Malaria Diagnostics Market Segmentation

Malaria Diagnostics Market, By Technology

·       Microscopy
·       Rapid Diagnostic Tests (RDTs)
·       Molecular Diagnostic Tests
·    Conventional PCR
·    Real-Time PCR (qPCR)

Malaria Diagnostics Market, By End User

·      Hospital 
·      Clinics
·      Diagnostic Centers

Malaria Diagnostics Market, By Region
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa


1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

    3. Market Dynamics

    • 3.1. Market Drivers
    • 3.2. Market Restraints
    • 3.3. Market Opportunities

    4. Key Insights

    • 4.1. Key Emerging Trends – For Major Countries
    • 4.2. Latest Technological Advancement
    • 4.3. Regulatory Landscape
    • 4.4. Industry SWOT Analysis
    • 4.5. Porters Five Forces Analysis

    5. Global Malaria Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 5.1. Key Findings / Summary
    • 5.2. Market Analysis, Insights and Forecast – By Technology
      • 5.2.1. Microscopy
      • 5.2.2. Rapid Diagnostic Tests (RDTs)
      • 5.2.3. Molecular Diagnostic Tests
        • 5.2.3.1. Conventional PCR
        • 5.2.3.2. Real-Time PCR (qPCR)
  • 5.3. Market Analysis, Insights and Forecast – By End User
    • 5.3.1. Hospital
    • 5.3.2. Clinics
    • 5.3.3. Diagnostic Centers
  • 5.4. Market Analysis, Insights and Forecast – By Region
    • 5.4.1. North America
    • 5.4.2. Latin America
    • 5.4.3. Europe
    • 5.4.4. Asia Pacific
    • 5.4.5. Middle East and Africa
  • 6. North America Malaria Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 6.1. Key Findings / Summary
    • 6.2. Market Analysis, Insights and Forecast – By Technology
      • 6.2.1. Microscopy
      • 6.2.2. Rapid Diagnostic Tests (RDTs)
      • 6.2.3. Molecular Diagnostic Tests
        • 6.2.3.1. Conventional PCR
        • 6.2.3.2. Real-Time PCR (qPCR)
  • 6.3. Market Analysis, Insights and Forecast – By End User
    • 6.3.1. Hospital
    • 6.3.2. Clinics
    • 6.3.3. Diagnostic Centers
  • 6.4. Market Analysis, Insights and Forecast – By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada
  • 7. Latin America Malaria Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 7.1. Key Findings / Summary
    • 7.2. Market Analysis, Insights and Forecast – By Technology
      • 7.2.1. Microscopy
      • 7.2.2. Rapid Diagnostic Tests (RDTs)
      • 7.2.3. Molecular Diagnostic Tests
        • 7.2.3.1. Conventional PCR
        • 7.2.3.2. Real-Time PCR (qPCR)
  • 7.3. Market Analysis, Insights and Forecast – By End User
    • 7.3.1. Hospital
    • 7.3.2. Clinics
    • 7.3.3. Diagnostic Centers
  • 7.4. Market Analysis, Insights and Forecast – By Country
    • 7.4.1. Brazil
    • 7.4.2. Mexico
    • 7.4.3. Rest of Latin America
  • 8. Europe Malaria Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 8.1. Key Findings / Summary
    • 8.2. Market Analysis, Insights and Forecast – By Technology
      • 8.2.1. Microscopy
      • 8.2.2. Rapid Diagnostic Tests (RDTs)
      • 8.2.3. Molecular Diagnostic Tests
        • 8.2.3.1. Conventional PCR
        • 8.2.3.2. Real-Time PCR (qPCR)
  • 8.3. Market Analysis, Insights and Forecast – By End User
    • 8.3.1. Hospital
    • 8.3.2. Clinics
    • 8.3.3. Diagnostic Centers
  • 8.4. Market Analysis, Insights and Forecast – By Country
    • 8.4.1. UK
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Russia
    • 8.4.7. Rest of Europe
  • 9. Asia Pacific Malaria Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 9.1. Key Findings / Summary
    • 9.2. Market Analysis, Insights and Forecast – By Technology
      • 9.2.1. Microscopy
      • 9.2.2. Rapid Diagnostic Tests (RDTs)
      • 9.2.3. Molecular Diagnostic Tests
        • 9.2.3.1. Conventional PCR
        • 9.2.3.2. Real-Time PCR (qPCR)
  • 9.3. Market Analysis, Insights and Forecast – By End User
    • 9.3.1. Hospital
    • 9.3.2. Clinics
    • 9.3.3. Diagnostic Centers
  • 9.4. Market Analysis, Insights and Forecast – By Country
    • 9.4.1. China
    • 9.4.2. India
    • 9.4.3. Japan
    • 9.4.4. Australia
    • 9.4.5. South East Asia
    • 9.4.6. Rest of Asia Pacific
  • 10. Middle East & Africa Malaria Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 10.1. Key Findings / Summary
    • 10.2. Market Analysis, Insights and Forecast – By Technology
      • 10.2.1. Microscopy
      • 10.2.2. Rapid Diagnostic Tests (RDTs)
      • 10.2.3. Molecular Diagnostic Tests
        • 10.2.3.1. Conventional PCR
        • 10.2.3.2. Real-Time PCR (qPCR)
  • 10.3. Market Analysis, Insights and Forecast – By End User
    • 10.3.1. Hospital
    • 10.3.2. Clinics
    • 10.3.3. Diagnostic Centers
  • 10.4. Market Analysis, Insights and Forecast – By Country
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa
  • 11. Competitive Analysis

    • 11.1. Company Market Share Analysis, 2018
    • 11.2. Key Industry Developments
    • 11.3. Company Profile
    • 11.4. Beckman Coulter/Danaher
      • 11.4.1. Business Overview
      • 11.4.2. Segment 1 & Service Offering
      • 11.4.3. Overall Revenue
      • 11.4.4. Geographic Presence
      • 11.4.5. Recent Development
    *Similar details will be provided for the following companies
    • 11.5. Abbott Laboratories
    • 11.6. Bio-Rad Laboratories, Inc.
    • 11.7. Novartis Diagnostics
    • 11.8. Life Technology
    • 11.9. Siemens Healthcare
    • 11.10. Bio-Rad
    • 11.11. Ortho-Clinical Diagnostics
    List of Figures

    Figure 1: Global Malaria Diagnostics Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
    Figure 2: Global Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 3: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 4: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 5: Global Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 6: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 7: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 8: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 9: Global Malaria Diagnostics Market Forecast (USD Billion), by Others, 2016-2027
    Figure 10: Global Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 11: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 12: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 13: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 14: Global Market Forecast (USD Billion), by Others, 2016-2027
    Figure 15: Global Market Value (USD Billion), by Region, 2019 & 2027
    Figure 16: North America Malaria Diagnostics Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 17: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 18: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 19: North America Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 20: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 21: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 22: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 23: North America Market Forecast (USD Billion), by Others, 2016-2027
    Figure 24: North America Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 25: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 26: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 27: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 28: North America Market Forecast (USD Billion), by Others, 2016-2027
    Figure 29: North America Market Forecast (USD Billion), by U.S., 2016-2027
    Figure 30: North America Market Forecast (USD Billion), by Canada, 2016-2027
    Figure 31: Latin America Malaria Diagnostics Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 32: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 33: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 34: Latin America Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 35: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 36: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 37: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 38: Latin America Market Forecast (USD Billion), by Others, 2016-2027
    Figure 39: Latin America Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 40: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 41: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 42: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 43: Latin America Market Forecast (USD Billion), by Others, 2016-2027
    Figure 44: Latin America Market Forecast (USD Billion), by Brazil, 2016-2027
    Figure 45: Latin America Market Forecast (USD Billion), by Mexico, 2016-2027
    Figure 46: Latin America Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
    Figure 47: Europe Malaria Diagnostics Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 48: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 49: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 50: Europe Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 51: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 52: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 53: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 54: Europe Market Forecast (USD Billion), by Others, 2016-2027
    Figure 55: Europe Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 56: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 57: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 58: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 59: Europe Market Forecast (USD Billion), by Others, 2016-2027
    Figure 60: Europe Market Forecast (USD Billion), by U.K., 2016-2027
    Figure 61: Europe Market Forecast (USD Billion), by Germany, 2016-2027
    Figure 62: Europe Market Forecast (USD Billion), by France, 2016-2027
    Figure 63: Europe Market Forecast (USD Billion), by Italy, 2016-2027
    Figure 64: Europe Market Forecast (USD Billion), by Spain, 2016-2027
    Figure 65: Europe Market Forecast (USD Billion), by Russia, 2016-2027
    Figure 66: Europe Market Forecast (USD Billion), by Rest of Europe, 2016-2027
    Figure 67: Asia Pacific Malaria Diagnostics Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 68: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 69: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 70: Asia Pacific Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 71: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 72: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 73: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 74: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
    Figure 75: Asia Pacific Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 76: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 77: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 78: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 79: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
    Figure 80: Asia Pacific Market Forecast (USD Billion), by China, 2016-2027
    Figure 81: Asia Pacific Market Forecast (USD Billion), by India, 2016-2027
    Figure 82: Asia Pacific Market Forecast (USD Billion), by Japan, 2016-2027
    Figure 83: Asia Pacific Market Forecast (USD Billion), by Australia, 2016-2027
    Figure 84: Asia Pacific Market Forecast (USD Billion), by Southeast Asia, 2016-2027
    Figure 85: Asia Pacific Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
    Figure 86: Middle East & Africa Malaria Diagnostics Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 87: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 88: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 89: Middle East & Africa Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 90: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 91: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 92: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 93: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
    Figure 94: Middle East & Africa Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 95: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 96: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 97: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 98: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
    Figure 99: Middle East & Africa Market Forecast (USD Billion), by GCC, 2016-2027
    Figure 100: Middle East & Africa Market Forecast (USD Billion), by South Africa, 2016-2027
    Figure 101: Middle East & Africa Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
    List of Tables
    Table 1: Global Malaria Diagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 2: Global Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 3: Global Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 4: Global Market Revenue (USD Billion) Forecast, by Region, 2016-2027
    Table 5: North America Malaria Diagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 6: North America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 7: North America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 8: North America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
    Table 9: Europe Malaria Diagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 10: Europe Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 11: Europe Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 12: Europe Market Revenue (USD Billion) Forecast, by Country, 2016-2027
    Table 13: Latin America Malaria Diagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 14: Latin America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 15: Latin America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 16: Latin America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
    Table 17: Asia Pacific Malaria Diagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 18: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 19: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 20: Asia Pacific Market Revenue (USD Billion) Forecast, by Country, 2016-2027
    Table 21: Middle East & Africa Malaria Diagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 22: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 23: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 24: Middle East & Africa Market Revenue (USD Billion) Forecast, by Country, 2016-2027
    Research Process

    Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.

    In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization

    FIGURE 1: DLR RESEARH PROCESS

    research-methodology1

    Primary Research

    Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.

    In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.

    It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.

    Secondary Research

    Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.

    Market Size Estimation

    Both, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.

    Forecast Model

    research-methodology2